Live from the NIH registry
Studies recruiting near Peoria right now
Top 25 of 217 recruiting studies, sorted by proximity — each links to its official registry page
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Care — Peoria, Illinois (4.3 mi)
· Sponsor: SCRI Development Innovations, LLC
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
OSF Saint Francis — Peoria, Illinois (4.3 mi)
· Sponsor: Abiomed Inc.
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Peoria, Illinois (4.3 mi)
· Sponsor: Daiichi Sankyo
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Peoria Pulmonary Associates Ltd- Site Number : 8400095 — Peoria, Illinois (4.3 mi)
· Sponsor: Sanofi
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
OSF HealthCare Cancer Institute — Peoria, Illinois (4.3 mi)
· Sponsor: Proton Collaborative Group
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Children's Oncology Group
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Illinois CancerCare — Peoria, Illinois (4.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Penumbra Inc.
A Study of ZL-1310 in Participants With Selected Solid Tumors
Solid Tumors
Phase 1, Phase 2
Interventional 166 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Morton, Illinois (12.6 mi)
· Sponsor: GlaxoSmithKline
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
Children's Hospital of Illinois at OSF-Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: St. Jude Children's Research Hospital
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Peoria, IL Investigative Site 10019 — Peoria, Illinois (4.3 mi)
· Sponsor: Colorado Prevention Center
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Stress Hydrocortisone In Pediatric Septic Shock
Septic Shock
Phase 3
Interventional 500 participants sought
The University of Illinois at Chicago/OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Jerry Zimmerman
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk061 — Peoria, Illinois (4.3 mi)
· Sponsor: Mirati Therapeutics Inc.
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Congenital Antithrombin Deficiency
Phase 3
Interventional 38 participants sought
Bleeding and Clotting Disorders Institute — Peoria, Illinois (4.3 mi)
· Sponsor: Octapharma
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: SurModics, Inc.
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Illinois CancerCare — Peoria, Illinois (4.3 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 310 participants sought
Osf Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: BeOne Medicines